Throughout September members of our team will be participating in investor events hosted by Wells Fargo, H.C. Wainwright & Co., LLC, Cantor Fitzgerald and Stifel Financial Corp. to highlight our progress and review our upcoming milestones with the investment community. Listen to the live or replay fireside chats: https://lnkd.in/gjR6XUvk #CantorHCC
Pliant Therapeutics
Biotechnology Research
South San Francisco, California 11,607 followers
We are transforming the lives of patients by developing best-in-class treatments for fibrotic diseases.
Über uns
Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases. We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases. Pliant recognizes the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. Pliant is an equal opportunity employer and does not discriminate against any individual or potential candidate based on race, color, religion, sex, national origin, sexual preference or any other legally protected category. Pliant is located in South San Francisco, California, the birthplace of biotechnology. Proud to be a San Francisco Business Times Best Place to Work in 2023. Learn more about how we are breaking ground in the treatment of fibrotic diseases at www.PliantRx.com.
- Website
-
http://www.pliantrx.com
External link for Pliant Therapeutics
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- South San Francisco, California
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2015
- Spezialitäten
- fibrosis, integrins, muscle biology, oncology, Duchenne muscular dystrophy, Idiopathic pulmonary fibrosis, Primary sclerosing cholangitis, muscular dystrophy, Metabolic dysfunction-associated steatohepatitis, and MASH
Standorte
-
Primäre
260 Littlefield Ave
South San Francisco, California 94080, US
Employees at Pliant Therapeutics
Aktualisierungen
-
We are excited to share our progress in the fight against fibrosis as part of oral late breaker and poster presentations at the European Respiratory Society Congress 2024 being held September 8 – 10. Attending #ERS2024? Visit members of #TeamPliant at Booth C8.17. Learn more https://lnkd.in/gsEr4kjx #ERS #ERS24
-
-
Today we announced our Second Quarter 2024 Financial Results and provided a company update. Read about our progress: https://lnkd.in/gPRAeFSA
-
-
Our Chief Financial Officer, Dr. Keith Cummings, and Chief Medical Officer, Dr. Eric Lefebvre, will join Canaccord Genuity - Global Capital Markets' analyst Edward Nash for a fireside chat on Wednesday, August 14th at 1:00 p.m. ET as part of Canaccord Genuity's 44th Annual Growth Conference. To listen live or via replay please visit: https://lnkd.in/gvgxAnNx #CGDriven #DrivenByYourSuccess
-
-
Pliant is committed to creating, nurturing and sustaining an inclusive culture. Part of this is our deeply rooted DEI initiatives that recognize and celebrate the cultural and professional contributions of each of our teammates. Learn more about our workplace culture and working with us: https://lnkd.in/gjPhTFf #TeamPliant
-
-
We are thrilled to welcome 8 talented and enthusiastic interns to the Pliant family as part of our 2024 Summer Internship Program. We look forward to their innovative ideas and fresh perspectives as they help advance our important work in the fight against fibrosis. #summerinternship
-
-
Join members of #TeamPliant this weekend as we kick off the 2024 PFF Walk Season in Pittsburgh, the City of Bridges. Please visit our booth and learn about BEACON-IPF, our global Phase 2b/3 trial, and the important work we are doing in the fight against fibrosis. #PFFWalk #PulmonaryFibrosis #TogetherTowardACure
Join us this weekend as we walk together toward a cure! 🌟 Held at North Shore Riverfront Park, the PFF Walk - Pittsburgh offers two course options – 1-mile or 2-mile – along a gorgeous waterfront pathway with spectacular views of the downtown skyline. After the Walk, we invite you to stay for a celebration with family-friendly activities and light refreshments. The PFF Walk unites everyone impacted by pulmonary fibrosis and provides a special opportunity to raise funds and awareness for the Pulmonary Fibrosis Foundation. Everyone who participates in the PFF Walk is making a valuable contribution to our collective effort toward a cure for pulmonary fibrosis. 💙 Registration is free and every dollar raised makes a difference in the lives of people with PF. Raise $100 or more and receive our official, commemorative t-shirt.🎉 Register now at PFFWalkPittsburgh.org! #PFFWalk #PulmonaryFibrosis #TogetherTowardACure
-
-
Today we announced positive 24-week data from our Phase 2a INTEGRIS-PSC trial in patients with primary sclerosing cholangitis. Learn more about these results: https://lnkd.in/gjr-_8iy
-
Congratulations to Pliant Board Director Katharine Knobil, M.D. for being recognized as member of the Directors to Watch Class of 2024 by Directors & Boards magazine. This recognition highlights Katharine's significant contributions to ensuring a robust board culture and maintaining corporate governance excellence. Congrats from all of #TeamPliant! Learn more about Katharine and this recognition: https://lnkd.in/gZz9GCyd
-
-
We are very pleased to welcome Steve Krognes to the Pliant board. Learn more about Steve: https://lnkd.in/g_AgHPMw
-
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 287.5M